Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The non-canonical endocytosis pathway, also called clathrin-independent endocytosis, encompasses a variety of cellular mechanisms for internalizing extracellular molecules, plasma membrane proteins, and other cargoes without relying on the classic clathrin-coated vesicles. These pathways include caveolin-mediated endocytosis (caveolae), fast endophilin-mediated endocytosis, macropinocytosis, CLIC/GEEC, and others, each with distinct molecular machinery and cargo preferences. Many viruses, toxins, and bacteria hijack these routes for cell entry. Unlike canonical (clathrin-mediated) endocytosis, these pathways do not depend on clathrin or its associated adaptor proteins, and may use alternative mechanisms such as receptor clustering, lipid raft domains, or actin-driven processes for vesicle formation and cellular uptake. Non-canonical endocytic pathways are essential for diverse physiological and pathological processes but do not constitute a druggable target as a single molecule or protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-canonical endocytosis pathway.